{"id":14276,"date":"2022-11-15T10:17:00","date_gmt":"2022-11-15T15:17:00","guid":{"rendered":"https:\/\/18fbf770e8.nxcli.io\/?post_type=whitepapers&#038;p=14276"},"modified":"2022-12-08T09:10:43","modified_gmt":"2022-12-08T14:10:43","slug":"walmart-bestatigt-3b-deal-uber-apotheken-opioid-verkaufe","status":"publish","type":"whitepapers","link":"https:\/\/napolilaw.lemonadestand.org\/de\/weise-papiere\/walmart-bestatigt-3b-deal-uber-apotheken-opioid-verkaufe\/","title":{"rendered":"Walmart best\u00e4tigt $3B-Deal \u00fcber Opioidverk\u00e4ufe von Apotheken"},"content":{"rendered":"<p>Walmart officially revealed a $3.1 billion offer Tuesday that ended thousands of lawsuits accusing its nationwide pharmacy network of fueling America&#8217;s deadly crisis of opioid abuse, echoing similar settlements involving CBS Pharmacy and Walgreens.<\/p>\n\n\n\n<p>The 10-figure proposal from Walmart Inc. &#8211; the world&#8217;s largest corporation and America&#8217;s third-largest pharmacy business &#8211; seeks to extinguish more than 2,000 lawsuits brought by cities, counties, states, and Native American tribes, as well as the potential legal claims of government entities that haven&#8217;t yet sued.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.law360.com\/classaction\/articles\/1549292\/walmart-confirms-3b-deal-over-pharmacies-opioid-sales\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Den Originalartikel finden Sie hier<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Walmart hat am Dienstag offiziell ein Angebot in H\u00f6he von $3,1 Milliarden bekannt gegeben, das Tausende von Klagen beendete, in denen sein landesweites Apothekennetzwerk beschuldigt wurde, Amerikas t\u00f6dliche Krise des Opioidmissbrauchs angeheizt zu haben, und \u00e4hnliche Vergleiche mit \u2026<\/p>","protected":false},"featured_media":0,"menu_order":19,"template":"","whitepaper_category":[254,75,253],"whitepaper-source":[],"class_list":["post-14276","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-opioid-epidemic","whitepaper_category-opioids-litigation","whitepaper_category-opioid-crisis"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepapers\/14276","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepapers\/14276\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/media?parent=14276"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepaper_category?post=14276"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepaper-source?post=14276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}